3330 Results
2

Healthline: Avian flu outbreak in the US: What to know right now

February 22, 2022

Health experts in the United States are monitoring an increase in cases of bird flu in several states, including Indiana, Kentucky and Virginia. In January, the United States Department of Agriculture detected the first U.S. bird flu case after a hunted wild bird tested positive for the virus in Colleton County, South Carolina. Experts reported that it was the H5N1 strain, a highly pathogenic avian influenza virus (HPAI) — the same strain responsible for fatal poultry outbreaks across Europe and Asia in late 2021. In a story on the increase in bird flu published by Healthline, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the experts cited.

3

Cincinnati.com: Chronic pain: Would changes in CDC opioid prescribing guidelines help those who have it?

February 21, 2022

In 2016, the Centers for Disease Control and Prevention (CDC) set opioid-prescribing guidelines for physicians. The idea was to offer doctors the best ways to protect people from an over-prescription of pain pills which had fueled the misuse of opioids and amplified cascading overdose deaths in the United States. While the goal was to protect patients, the impact was not all positive. In an article published by Cincinnati.com, Christine Wilder, MD, of the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine and the director of the UC Health Addiction Sciences, was one of the experts cited.

6

WCPO: Tri-State recognizes Transgender Day of Visibility

March 31, 2022

March 31 is Transgender Day of Visibility and some events are marking the day in Cincinnati. Attention is also being brought to the transgender medicine program started in 2016 at the UC College of Medicine by Sarah Pickle, MD, of the Department of Family and Community Medicine. WCPO interviewed fourth-year medical student Malia Schram about the program.

7

Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence?

April 14, 2022

A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 armamentarium. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.